Intravenous immune globulin therapy for neurologic diseases.

  title={Intravenous immune globulin therapy for neurologic diseases.},
  author={Marinos C. Dalakas},
  journal={Annals of internal medicine},
  volume={126 9},
Ever since Imbach and colleagues [1], in 1981, first observed that children with idiopathic thrombocytopenic purpura respond to high-dose intravenous immune globulin (IVIg) therapy, this therapy has been used in a wide range of autoimmune diseases, various primary immunodeficiencies, and the Kawasaki syndrome [2-6]. Since the last review on this subject was published 7 years ago [2], IVIg has emerged as a powerful therapy for various neurologic disorders [7]. In neurology, probably more than in… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 62 extracted citations


Publications referenced by this paper.
Showing 1-10 of 91 references

A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barre syndrome. Dutch Guillain-Barre Study Group

  • FG vanderMeche, PI Schmitz
  • N Engl J Med
  • 1992
Highly Influential
4 Excerpts

Intravenous Immunoglobulin Research and Therapy

  • MD Kazatchkine, A Morell, eds
  • New York: Parthenon Publishing
  • 1996
Highly Influential
4 Excerpts

Principles of Clinical Chemistry

  • KE Blick, SM Liles
  • New York: J Wiley; 1985:401-4
  • 1997
1 Excerpt

Similar Papers

Loading similar papers…